CAS RN: 1007884-60-7

Daclatasvir Impurity F

Product Availability

Choose a grade to view its available package options.

1 package records0 with current stock1 grade group
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250530 5mg / 10mg Out of stock 15 business days Inquiry
  • Product code: starshine_CAS1007884-60-7
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1007884-60-7 / methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate

Monodes(N-carboxymethyl)valine Daclatasvir | methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate | Daclatasvir Impurity A (TFA)

Standard CAS: 1007884-60-7 Multi CAS: Yes

Basic Information

CAS
1007884-60-7
Multi CAS
Yes
Molecular Formula
C33H39N7O3
Molecular Weight
581.700000
Exact Mass
581.311438
SMILES
CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6)NC(=O)OC
InChI
InChI=1S/C33H39N7O3/c1-20(2)29(39-33(42)43-3)32(41)40-17-5-7-28(40)31-36-19-27(38-31)24-14-10-22(11-15-24)21-8-12-23(13-9-21)26-18-35-30(37-26)25-6-4-16-34-25/h8-15,18-20,25,28-29,34H,4-7,16-17H2,1-3H3,(H,35,37)(H,36,38)(H,39,42)/t25-,28-,29-/m0/s1
InChIKey
BHLPGQSNBFUPQA-FMYROPPKSA-N
Synonyms
Monodes(N-carboxymethyl)valine Daclatasvir methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate Daclatasvir Impurity A (TFA) Daclatasvir Impurity 22 Daclatasvir Impurity 40

Computed Properties

Structural Parameters

Heavy atom count
43
Aromatic heavy atom count
22
Fraction Csp3
0.39
Rotatable bonds
8
H-bond acceptors
6
H-bond donors
4
Molar refractivity
164.87
TPSA
128.03

LogP / Solubility

WLOGP
5.6
MLOGP
4.98
XLogP3
4
Consensus LogP
4.86
Log S (ESOL)
-6.83
Class (ESOL)
Insoluble
Log S (Ali)
-8.38
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-9.05
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.29

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.56
Leadlikeness
No
Synthetic Accessibility
7

Get In Touch

Contact Us